Company Filing History:
Years Active: 2022
Title: Robert Bahde: Innovator in Stereoselective Synthesis
Introduction
Robert Bahde is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of chemistry, particularly in the area of stereoselective synthesis. His work has implications for the manufacturing of important nucleosides.
Latest Patents
Robert Bahde holds a patent for "Stereoselective synthesis and process for the manufacturing of 2'-deoxynucleosides." This patent discloses methods for the stereoselective synthesis and manufacturing of 2'-deoxynucleosides, including 2'-ribonucleosides. The patent details that the 2'-deoxynucleoside can be a β-anomer of a 2'-deoxynucleoside with a 3' α hydroxyl and 4' β hydroxymethyl configuration. Nonlimiting examples of compounds prepared by these methods include 4'-thio-2'-deoxycytidine (T-dCyd) and 5-aza-4'-thio-2'-deoxycytidine (5-aza-T-dCyd; aza-T-dCyd; aza-T-dC).
Career Highlights
Throughout his career, Robert Bahde has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and Alchem Laboratories Corporation. His experience in these institutions has contributed to his expertise in the field of nucleoside synthesis.
Collaborations
Robert has collaborated with notable colleagues such as Lianhao Zhang and Baburao Vishnuvajjala. These collaborations have further enhanced his research and development efforts in the field.
Conclusion
Robert Bahde's innovative work in stereoselective synthesis has led to advancements in the manufacturing of crucial nucleosides. His contributions continue to impact the field of chemistry and biotechnology.